<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Endothelin-1 Overexpression Improves Renal Function in eNOS Knockout Mice</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-10-29">October 29, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Prof</roleName><surname>Berthold Hocher</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Oleg</forename><surname>Tsuprykov</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Nutritional Science</orgName>
								<orgName type="institution">University of Potsdam</orgName>
								<address>
									<settlement>Potsdam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Cardiovascular Research</orgName>
								<address>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lyubov</forename><surname>Chaykovska</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Clinic for Cardiovascular Surgery</orgName>
								<orgName type="institution">University Hospital of Zürich</orgName>
								<address>
									<settlement>Zürich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Axel</forename><surname>Kretschmer</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Bayer HealthCare AG</orgName>
								<address>
									<settlement>Wuppertal</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johannes-Peter</forename><surname>Stasch</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Bayer HealthCare AG</orgName>
								<address>
									<settlement>Wuppertal</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Institute of Pharmacy</orgName>
								<orgName type="institution">University of Halle-Wittenberg, Halle (Saale)</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thiemo</forename><surname>Pfab</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Center for Cardiovascular Research</orgName>
								<address>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katharina</forename><surname>Krause-Relle</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Nutritional Science</orgName>
								<orgName type="institution">University of Potsdam</orgName>
								<address>
									<settlement>Potsdam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Cardiovascular Research</orgName>
								<address>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christoph</forename><surname>Reichetzeder</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Nutritional Science</orgName>
								<orgName type="institution">University of Potsdam</orgName>
								<address>
									<settlement>Potsdam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Cardiovascular Research</orgName>
								<address>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Philipp</forename><surname>Kalk</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Nephrology</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Charité, Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jerzy</forename><surname>Adamski</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute of Experimental Genetics</orgName>
								<orgName type="institution" key="instit1">Helmholtz Zentrum München</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<orgName type="institution" key="instit3">Genome Analysis Center</orgName>
								<address>
									<settlement>Neuherberg</settlement>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Chair of Experimental Genetics</orgName>
								<orgName type="institution">Technische Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">German Center for Diabetes Research</orgName>
								<orgName type="institution">Neuherberg, j Diaverum</orgName>
								<address>
									<settlement>Potsdam</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Berthold</forename><surname>Hocher</surname></persName>
							<email>hocher@uni-potsdam.de</email>
							<affiliation key="aff1">
								<orgName type="department">Institute for Nutritional Science</orgName>
								<orgName type="institution">University of Potsdam</orgName>
								<address>
									<settlement>Potsdam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="institution">IFLb Laboratoriumsmedizin Berlin GmbH</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Chao</forename><forename type="middle">L</forename><surname>Chao</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><forename type="middle">:</forename><surname>Cell</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Zucker</forename><surname>Sn</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fink</forename><surname>Ee</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bogner</forename><surname>Pn</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Wawrzyniak</forename><surname>Ja</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Foley</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Leonova</forename><surname>Ki</surname></persName>
						</author>
						<author>
							<persName><roleName>Moparthy K, Ionov</roleName><forename type="first">Grimm</forename><surname>Mj</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Wang</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kandel</forename><surname>Es</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bakin</forename><surname>Av</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">N</forename><surname>Kaminski</surname></persName>
						</author>
						<author>
							<persName><surname>Segal</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Institute of Nutritional Science</orgName>
								<orgName type="institution">University of Potsdam 14558 Nuthetal</orgName>
								<address>
									<settlement>Potsdam</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Endothelin-1 Overexpression Improves Renal Function in eNOS Knockout Mice</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-10-29">October 29, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">237FE5F70B7FC432707533A036C33083</idno>
					<idno type="DOI">10.1159/000438516</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:42+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Chronic kidney disease</term>
					<term>Endothelial nitric oxide synthase</term>
					<term>Endothelin</term>
					<term>Mice</term>
					<term>Nitric oxide</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background/Aims: To investigate the renal phenotype under conditions of an activated morphology in wild-type, ET-1 transgenic (ET+/+), endothelial nitric oxide synthase knockout (eNOS-/-) and ET+/+eNOS-/-mice.</s><s>Methods: We assessed blood pressure, parameters of renal morphology, plasma cystatin C, urinary protein excretion, expression of genes using metabolomics.</s><s>Results: eNOS-/-and ET+/+eNOS-/-mice developed hypertension.</s><s>Osteopontin, albumin and protein excretion were increased in eNOS-/-and restored in and glomerulosclerosis.</s><s>Genes involved in tissue remodeling (serpine1, TIMP1, Col1a1, CCL2) were up-regulated in eNOS-/-, but not in ET+/+eNOS-/-mice.</s><s>Plasma levels of free carnitine and acylcarnitines, amino acids, diacyl phosphatidylcholines, lysophosphatidylcholines and hexoses were descreased in eNOS-/-and were in the normal range in ET+/+eNOS-/-mice.</s><s>Conclusion: eNOS-/-mice developed renal dysfunction, which was partially rescued by ET-1 overexpression in eNOS-/-mice.</s><s>The metabolomics results suggest that ET-1 overexpression on top of eNOS knockout is associated with a functional recovery of mitochondria (rescue of monounsaturated fatty acids levels).</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Endothelin-1 (ET-1) and nitric oxide (NO) closely interact in a manner of a local network, i.e.</s><s>ET-1 stimulates NO production, NO in turn inhibits ET-1 expression proportionally in different cell-types <ref type="bibr">[1]</ref>.</s><s>An in vivo example of interaction between ET-1 and NO production was demonstrated in transgenic mice overexpressing ET-1 (ET+/+), which have a normal blood pressure.</s><s>The vasoconstrictory effects of ET-1 were antagonized by an increased production of NO, the endothelial counterpart of ET-1 in animals overexpressing .</s></p><p><s>An excessive renal production of ET-1 is often observed in patients with chronic kidney disease (CKD) of diabetic and non-diabetic origin <ref type="bibr">[3]</ref>.</s><s>In contrast, in CKD the overall NO availability is decreased, in part due to endothelial dysfunction <ref type="bibr">[4]</ref>.</s><s>To date, the only known agents to block the activity of ET-1, which have been approved for clinical use, are ET receptor antagonists <ref type="bibr">[5]</ref>, although they have not so far been validated for a therapeutic use in CKD due to adverse effects such as water and salt retention <ref type="bibr">[3,</ref><ref type="bibr">6]</ref>.</s></p><p><s>We have previously generated crossbred animals of ET transgenic mice (ET+/+) and endothelial nitric oxide synthase knockout (eNOS-/-) mice to investigate the role of ET-1 overproduction in endothelial function and blood pressure in the conditions of NO /-and ET+/+eNOS-/-mice developed high blood pressure in contrast to wild-type (WT) and ET+/+ mice, which remained normotensive <ref type="bibr">[8]</ref>.</s><s>Interestingly, left ventricular catheterization showed that only eNOS-/-mice, but not ET+/+eNOS-/-developed diastolic dysfunction <ref type="bibr">[8]</ref>.</s><s>The aim of the present work was to investigate renal phenotypic consequences and mechanisms of ET/eNOS interaction using crossbred ET+/+eNOS-/-mice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mouse model</head><p><s>Human ET-1 transgenic mice (line 856) <ref type="bibr">[9]</ref> and eNOS-/-mice <ref type="bibr" target="#b5">[10]</ref> were generated as described previously.</s><s>Only homozygous mice were used for breeding.</s><s>We ensured the steadiness of the genotype over the generations.</s><s>Crossbred mice were created by breeding female eNOS-/-mice with male ET+/+.</s><s>Study groups were composed as follows: WT, ET+/+, eNOS-/-, and ET+/+eNOS-/-mice.</s><s>The number of animals</s></p><p><s>The protocol was approved by the Committee on the Ethics of Animal Experiments of the city of Berlin, Germany.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood pressure months).</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histological studies</head><p><s>to the total area of the picture was analyzed using the program ImageJ (shareware by National Institutes acid-Schiff positive area within the glomerulus by a semi-quantitative score system using a score of 1-4 by two investigators who were blinded to the study groups.</s><s>Scores 1, 2, 3, and 4 represented mesangial matrix Plasma and urinary analyses Urinary concentrations of albumin, H-FABP, and osteopontin were determined in urine samples collected in a six hours time period in metabolic cages.</s><s>ELISA assays were conducted to determine the levels of albumin (CellTrend GmbH kit.</s><s>no.</s><s>50200, Luckenwalde, Germany), H-FABP (Hycult Biotech, kit no.</s><s>HK403, protocols provided by the suppliers of the assays.</s><s>Optical density of the samples was measured at 450 nm creatinine, albumin, and protein were quantitatively determined in the samples using a Cobas Integra 400 Systems Inc. (Minneapolis, MN, USA) according to manufacturer's guidelines with readout performed with Western blotting .</s><s>separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Amersham TM Hybond TM ECL, GE Healthcare, Milwaukee, USA) in transfer buffer (184 mM Glycin, 24 mM Tris, 20% methanol) at 110 V for 2.5 hours.</s><s>Membranes were blocked in 5% non-fat milk TBS-T for Aldrich, Steinheim, Germany) were used.</s></p><p><s>Germany) and checked for integrity on a Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).</s><s>For Carlsbad, CA, USA) for 15 minutes at room temperature and then reverse-transcribed with the use of ImProm well microtiter plates.</s><s>cDNA samples (20 ng) were run in triplicates in reaction volumes of 20 μl (384-well microtiter plates) under standard thermocycler conditions.</s><s>TaqMan probe sets were generated by using Primer3Plus ( was calculated using the ddCt term (Applied Biosystems, User Bulletin No. 2) related to endogenous controls the following NCBI GenBank accession numbers (Table <ref type="table" target="#tab_1">1</ref>).</s></p><p><s>IDQ TM p150 kit injection analysis) <ref type="bibr">[12,</ref><ref type="bibr">13]</ref>.</s><s>The assay includes free carnitine, 40 acylcarnitines (Cx:y), 14 amino acids (13 proteinogenic + ornithine), hexoses (sum of hexoses -about 90-95 % glucose), 92 glycerophospholipids</s></p><p><s>The abbreviations Cx:y are used to describe the total number of carbons and double bonds of all chains, respectively <ref type="bibr">[13]</ref>.</s><s>Mass spectrometric (MS) analyses were done on a API 4000 system (AB Sciex Deutschland GmbH, Darmstadt, Germany) equipped with a 1200 Series HPLC (Agilent Technologies Deutschland GmbH, Böblingen, Germany) and a HTC PAL auto sampler (CTC Analytics, Zwingen, Switzerland) controlled by the of metabolite concentrations as well as quality assessment was performed with the MetIQ™ software, which is an integral part of the AbsoluteIDQ™ kit (both from Biocrates Life Sciences AG, Innsbruck, Austria).</s></p><p><s>The AbsoluteIDQ TM p150 kit has been proven to be in conformance with FDA-Guidline "Guidance for Industry -Bioanalytical Method Validation" (May 2001) <ref type="bibr">[14]</ref>, which implies proof of reproducibility within a given error range.</s><s>The metabolite panel covered by targeted metabolomics approach has been succesfully used to evaluate mechanistic background of phenotypes observed in human <ref type="bibr">[15]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>All data are expressed as means ± SEM.</s><s>Statistical analyses were performed using GraphPad Prism 5 software (La Jolla, CA, USA).</s><s>For comparison of two parametrically distributed groups of data unpaired t-test with equal or unequal variance (Welch's correction) was applied.</s><s>For nonparametrically distributed when P &lt; 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Systolic blood pressure P &lt; 0.001 versus WT) P &lt; 0.05 versus WT) compared to WT (111.9 ± 4.2 tendencies were revealed starting as early as 3 months of age (Table <ref type="table" target="#tab_2">2</ref>).</s><s>SBP in eNOS-/-Plasma cystatin C was elevated in both groups with eNOS genetic ablation (P &lt; 0.05 versus WT), but not in ET+/+ mice (Fig. <ref type="figure" target="#fig_0">1a</ref>).</s><s>In contrast, albuminuria and proteinuria were P &lt; 0.01 versus WT) increased only in eNOS-/-compared to WT (15.0control.</s><s>Interestingly, in crossbred mice both albuminuria and proteinuria levels were observed to be diminished compared to eNOS-/-(P &lt; 0.01 versus eNOS-/-).</s><s>Urine biomarkers Urinary excretion of osteopontin was 3.4-fold increased in eNOS-/-mice versus WT (P &lt; 0.01) and restored in crossbred mice versus eNOS-/-(P &lt; 0.001, Fig. <ref type="figure" target="#fig_1">2a</ref>).</s><s>Urinary excretion of heart muscle-type fatty acid binding protein (H-FABP, measured in ng/24h) was the genotypes (Fig. <ref type="figure" target="#fig_1">2b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Kidney morphology</head><p><s>ET+/+eNOS-/-versus WT, whereas in the eNOS-/-group it was lower compared to all other groups (Table <ref type="table" target="#tab_3">3</ref>).</s><s>ET+/+, eNOS-/-and ET+/+eNOS-/-mice all developed glomerulosclerosis, as assessed by increased deposits of periodic acid Schiff (PAS) positive material within the groups.</s></p><p><s>The eNOS protein expression was increased in the ET+/+ group (P &lt; 0.01 versus WT).</s></p><p><s>in Table <ref type="table" target="#tab_4">4</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cellular Physiology and Biochemistry</head><p><s>Podocyte-associated genes (podocalyxin-like protein 1, nephrin and integrin alpha 3 subunit) showed only minor regulation patterns (Fig. <ref type="figure">3a-c</ref>).</s><s>In contrast, glomerular basement membrane (GBM) -associated genes were differently regulated.</s><s>In ET+/+ and eNOS-/-mice a down-regulation of collagen IV gene expression was observed, whereas the gene encoding one of the laminin subunits (Lamc1) was up-regulated.</s><s>Lamb2, a gene responsible for the synthesis of another laminin subunit, showed a trend (P = 0.056 versus WT) towards up-regulation in eNOS-/-mice.</s><s>Crossbred animals showed only a minor regulation of GBM associated genes (Fig. <ref type="figure">3d-f</ref>).</s><s>Endothelial cells-associated genes CD34 and up-regulated in eNOS-/-animals compared to WT. Col1a1 gene showed a trend towards upin the ET+/+eNOS-/-mice.</s><s>Interleukin 18 gene expression was up-regulated in ET+/+ mice versus all other groups (Fig. <ref type="figure" target="#fig_4">4f</ref>).</s><s>The angiotensin I-converting enzyme 2 (ACE2) gene was down-regulated in eNOS-/-animals compared to all other groups (Fig. <ref type="figure" target="#fig_4">4g</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasma metabolites</head><p><s>Free carnitine and acyl carnitines (Fig. <ref type="figure" target="#fig_5">5</ref>), diacyl phosphatidylcholines (PCaa), exhibited a similar pattern, in which the metabolites in eNOS-/-or transgenic ET+/+ were lower in concentration, whereas these metabolites of crossbred (ET+/+eNOS-/-) animals were comparable in concentration to those found in WT animals.</s><s>We did not observe changes in the activity of mitochondrial carnitine palmitoyl transferase I in any of the transgenic models, as depicted by a stable CPT-I ratio (calculated from octadecanoylcarnitine + hexadecanoylcarnitine/carnitine free (C18+C16)/C0).</s><s>The oxidative degradation of even-   Total alkyl-alkyl phosphatidylcholines PCaa showed a rescue effect but total acyl-alkylphosphatidylcholines (PCae) did not (Fig. <ref type="figure" target="#fig_6">6g-i</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>We compared kidney function and morphology in wild-type mice, ET-1 transgenic (ET+/+) mice, endothelial nitric oxide synthase knockout (eNOS-/-) mice, and ET+/+eNOS-/crossbred mice to investigate the renal phenotype under conditions of an activated renal of eNOS leads to the development of proteinuria, which is improved by overexpression of that the restoration of the markedly increased protein/albumin excretion in eNOS knockout mice might be due to a normalization of gene expression involved in glomerular basement integrity.</s><s>Increased urinary osteopontin excretion, (Fig. <ref type="figure" target="#fig_1">2a</ref>) as well as renal expression of by ET-1 overexpression.</s><s>In order to identify potential mechanisms leading to the restoration of the renal phenotype of eNOS-/-mice, we performed metabolomic analyses.</s><s>These analyses indicated that ET-1 overexpression, in addition to an eNOS knockout is associated increase in antioxidative properties (normalization of monounsaturated fatty acids levels).</s></p><p><s>Importantly, the phenotype of the ET-1 transgenic mice did not exhibit a measurable earlier reports indicating that kidney function in these animals starts to decrease in later stages (&gt;12 months) <ref type="bibr">[9]</ref>.</s><s>Protein excretion was only seen in eNOS-/-mice <ref type="bibr" target="#b9">[21]</ref><ref type="bibr">[22]</ref><ref type="bibr">[23]</ref>, but not in ET+/+ as reported earlier <ref type="bibr">[9,</ref><ref type="bibr">24,</ref><ref type="bibr">25]</ref>.</s><s>ET-1 overexpression on its own does not cause proteinuria, but in cases of underlying proteinuric renal diseases, such as pediatric nephrotic syndrome or diabetic renal disease, an activated ET-system enhances protein excretion <ref type="bibr">[26]</ref>.</s><s>Blood pressure was normal in ET-1+/+ mice, most likely due to an activated NO system  generations of ET+/+eNOS-/-mice, the blood pressure was similar in eNOS-/-mice and ET+/+eNOS-/-mice <ref type="bibr">[8,</ref><ref type="bibr">24,</ref><ref type="bibr">25]</ref>.</s><s>The reasons why the blood pressure phenotype changes slightly over the years is still unknown.</s><s>One of the reasons for a leakage of plasma proteins into the urine might be a damaged basement membrane (GBM) and endothelial cells.</s><s>Albumin-and proteinuria can be caused by disturbances of any GFB element <ref type="bibr">[28]</ref>.</s><s>In order to better understand the morphology of lined by a layer of interdigitating podocyte foot processes from the urinary-space side.</s><s>Our seen in ET+/+eNOS-/-mice (Fig. <ref type="figure">3</ref>).</s></p><p><s>The GBM itself is composed of extracellular matrix proteins assembled through an interweaving of type IV collagen with laminins, nidogen, and sulfated proteoglycans <ref type="bibr">[29]</ref>.</s><s>Any changes in the balance of extracellular matrix proteins within GBM may lead to an increased permeability.</s><s>The eNOS-/-mice were characterized by pronounced changes in expression of WT), while Lamb2 showed a trend towards up-regulation (P = 0.056 versus WT).</s><s>Similar, although less pronounced changes were revealed in ET+/+ mice, whereas in crossbreds GBM associated gene expression was similar to WT (Fig. <ref type="figure">3d-f</ref>).</s><s>Mutations in genes encoding proteins, including integrins are known to act as osteopontin receptors <ref type="bibr">[32]</ref>.</s><s>Although their interaction in the context of renal dysfunction is not clear yet, it is known that osteopontin is osteopontin observed in eNOS-/-(Fig.</s><s><ref type="figure" target="#fig_1">2</ref>) was consistent with an elevation of SBP (Table <ref type="table" target="#tab_1">1</ref>).</s><s>In addition, we further analyzed renal expression of genes involved in tissue remodeling.</s><s>In agreement with our assumption, increased urinary osteopontin excretion together with an up-regulation of osteopontin binding proteins Lamb2 and Lamc1 was accompanied by an upet al. previously reported that decreased NO levels in the kidney aggravated renal dysfunction, damage, hypertrophy, serum creatinine, blood urea nitrogen and urinary protein levels, accompanied by increases inhibitors of metalloproteinases <ref type="bibr">[34]</ref>.</s><s>Therefore, we suggest that the proteinuric phenotype in eNOS knockout mice is caused, at least partially, by an impaired GBM composition, which is improved in crossbred animals (Fig. <ref type="figure">3d-f</ref>).</s></p><p><s>Our current data of an improvement of the functional consequences of a systemic eNOS Moreover, L-NAME may also have blocked the other isoforms of NOS, which was not the case in our model.</s><s>In the present study, we observed a reduction of urinary protein excretion by ET-1 overexpression on top of eNOS-/-genotype.</s><s>This is somewhat in contradiction with were shown to have much more pronounced renoprotective effect than nonselective ones.</s></p><p><s>excretion, SBP, or kidney morphology parameters in uremic rats with 5/6 nephrectomy <ref type="bibr">[38]</ref>.</s></p><p><s>The aforementioned effects of ET antagonists were investigated in CKD models such as 5/6 nephrectomy or diabetic nephropathy, however the pathophysological conditions induced in these models are different in comparison to the model used in our study, in which ET-1 overexpression was not combined with any other insult to the kidney.</s><s>The kidney is very active in carnitine metabolism and releases the metabolites into the plasma and urine <ref type="bibr">[39]</ref>.</s><s>The metabolic pattern observed in the ET+/+eNOS-/-animals suggests a functional recovery of mitochondria.</s><s>This effect is prominent for internal mitochondrial enzymes but not for the carnitine shuttle <ref type="bibr">EC 2.3.1.21) [40]</ref>.</s><s>Furthermore, the same rescue effect is seen in oxidation of even-numbered fatty acids and overall activity oxidative damage in the renal cortex of hypertensive rats <ref type="bibr">[42]</ref>.</s><s>It results in an up-regulation of both antioxidant enzymes and eNOS <ref type="bibr">[43]</ref>.</s><s>Desaturation of fatty acid chains in the PC(aa) or carnitines abrogates the differences observed between WT, eNOS -/-and ET +/+, which is in agreement with the observation that saturated fatty acids (e.g.</s><s>palmitic acids) activate and the underlying mechanisms were reported.</s><s>In erythrocyte membrane lipid composition monounstaturated fatty acids (MUFA) are increased in non-diabetic patients with continuous ambulatory peritoneal dialysis <ref type="bibr">[45]</ref>.</s><s>In addition, MUFAs are increased in the plasma of activity <ref type="bibr">[49]</ref>.</s><s>Lysophosphatidylcholines (LPCs) are more sensitive to desaturation changes as they are composed of only one hydrocarbon chain instead of two present in the PCaas and PCaes.</s><s>Peroxisomal metabolism of phosphatidylcholines is not affected in any of the models (neither single nor double mutants) included in our study as the levels of PC(ae)s were not affected <ref type="bibr">[50]</ref>.</s></p><p><s>Similarly to concentrations of carnitines and lipids, the amino acid levels are normalized in ET+/+eNOS-/-animals.</s><s>This is of interest as these metabolites are biomarkers of complex diseases like diabetes type 2 and CKD.</s><s>Arginine is a known precursor of <ref type="bibr">NO [51]</ref>  with CKD and heart failure.</s><s>We have demonstrated that the functional consequences of a lack by overexpression of ET-1.</s><s>We suggest that this might be due to a functional recovery of properties (normalization of monounsaturated fatty acids levels).</s><s>The current study is in agreement with a previous report showing that eNOS knockout mice develop diastolic PCae-phosphatidylcholine acylalkyl-chains, PCaa -phosphatidylcholine acylacyl-chains, TCA-tricarboxylic acid cycle, ET-1 -endothelin 1, Nrf2 -nuclear factor (erythroid-derived 2)-like 2, elF4E -eukaryotic trans-dysfunction which could be restored by ET-1 overexpression in the heart.</s><s>This study the regulation of cardiac proteins playing a role in oxidative stress, myocyte contractility, and energy metabolism <ref type="bibr">[8]</ref>.</s><s>Thus, besides the fact that blockade of both the ETA and ETB receptors may lead to water and salt retention <ref type="bibr">[3,</ref><ref type="bibr">5,</ref><ref type="bibr">6]</ref>, our current data further challenges the idea to block the endothelin system in patients with endothelial dysfunction, as it is present in CKD due to diabetic nephropathy.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Plasma cystatin C levels (a), urinary albumin (b) and protein (c) daily excretion.</s><s>Values are given as mean ± SEM. * P &lt; 0.05, ** P &lt; 0.01.</s></p></div></figDesc><graphic coords="5,118.97,201.43,374.71,129.85" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Values are given as mean ± SEM. * P P *** P &lt; 0.001.</s></p></div></figDesc><graphic coords="5,235.61,369.73,263.29,131.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>-thelin receptor type B (ET-B), endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) in 9 months old mice.</s><s>Values are given as mean ± SEM. ** P &lt; 0.01 vs WT numbered fatty acids in mitochondria (characterized by carnitine free/acetylcarnitine (C2/ C0) ratio) compared to the overall activity of ß-oxidation (measured by acetylcarnitine + propionylcarnitine/carnitine free (C2+C3)/C0) ratio) revealed the aforementioned pattern representative of each metabolite class.</s><s>Desaturation of fatty acid chains in the PC(aa) or acyl carnitines abrogated the of their saturation level, revealed differences between WT, eNOS-/-and ET+/+ (Fig. 6d-f).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig</head><label></label><figDesc><div><p><s>Fig. 3.unit (c)), glomerular basement membrane-(collagen IV alpha 1 (d), laminin beta 2 (e), laminin gamma 1 (f)) and endothelial cells-associated genes (cluster of differentiation 34 (g) and cluster of differentiation 31 (h)) in whole kidney.</s><s>Values are given as mean ± SEM. * P P P &lt; 0.001.</s></p></div></figDesc><graphic coords="7,97.19,117.73,401.95,487.51" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. plasminogen activator inhibitor-1 (a), tissue inhibitor of metalloproteinase 1 (TIMP-1) (b), collagen type I alpha 1 (c), connective tissue growth factor (d), chemokine (C-C motif) ligand 2 / monocyte chemoattractant protein-1 (e), interleukin 18 (f), angiotensin I-converting enzyme 2 (ACE2) (g).</s><s>Values are given as mean ± SEM. * P P P &lt; 0.001.</s></p></div></figDesc><graphic coords="8,94.31,116.95,406.75,248.83" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 5 .</head><label>5</label><figDesc><div><p><s>Fig. 5. Plasma levels of free carnitine (a), acetylcarnitine (b), carnitine free/acetylcarnitine ratio (c), acetylcarnitine + propionylcarnitine/carnitine free ratio (d), dodecenoyl-L-carnitines C12 and C12:1 (e and f), tiglyl-L-carnitine (g), glutaconyl-L-carnitine (h).</s><s>Values are given as mean ± SEM. * P &lt; 0.05, ** P &lt; 0.01, *** P &lt; 0.001.</s></p></div></figDesc><graphic coords="8,94.73,442.93,404.53,230.59" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 6 .</head><label>6</label><figDesc><div><p><s>Fig. 6.</s><s>Plasma levels of phosphatidylcholine diacyls C30:0 (a) and C30:2 (b), mono-unsaturated glycerophosphocholines (c), lysophosphatidylcholine acyls C18:0 (d), C18:1 (e) and C18:2 (f), total lysophosphatidylcholines (g), total diacyl-containing phosphatidylcholines (h) and total acyl-alkyl-containing phosphatidylcholines (i).</s><s>Values are given as mean ± SEM. * P &lt; 0.05, ** P &lt; 0.01.</s></p></div></figDesc><graphic coords="9,97.97,120.79,401.17,445.75" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig. 7 .</head><label>7</label><figDesc><div><p><s>Fig. 7. Plasma levels of arginine (a), histidine (b), phenylalanine (c), leucine (d), threonine (e), valine (f), methionine (g) and tryptophan (h).</s><s>Values are given as mean ± SEM. * P &lt; 0.05, ** P &lt; 0.01, *** P &lt; 0.001.</s></p></div></figDesc><graphic coords="10,98.15,117.43,400.45,229.21" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 8 .</head><label>8</label><figDesc><div><p><s>Fig. 8. Plasma levels of hexoses (a) and sphingomyeline C16:0 (b).</s><s>Values are given as mean ± SEM. * P &lt; 0.05, ** P &lt; 0.01, *** P &lt; 0.001.</s></p></div></figDesc><graphic coords="10,203.99,391.51,296.59,163.21" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head></head><label></label><figDesc><div><p><s>/-, but not ET+/+eNOS-/-mice, developed cardiac dysfunction manifested in increased end diastolic pressure and time of left ventricular relaxation [8].</s><s>Cardioprotective properties of ET-1 overexpression on top of eNOS knockout were explained by reduction of cardiac oxidative et al. reported that in patients with CKD plasma ET-1 levels positively correlated with left ventricular hypertrophy [35].</s><s>The opposite effects of ET-1 overproduction in two different settings might be explained by a big heterogeneity within the patient cohort (concomitant chronic diseases, age, race etc. are the factors affecting organ function independently of ET-1 production) in the clinical trial, while our preclinical study was conducted in mice lines antagonist T-0115 ameliorated glomerulosclerosis, the rise in SBP, and prevented left ventricular hypertrophy in rats with G -nitro-l-arginine methyl ester (L-NAME) induced inhibition of NO synthesis [36].</s><s>The differences in the results might be explained by the fact study by Nakamura et al.</s><s>NO production was blocked only for a given time frame.</s><s>In addition,</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head></head><label></label><figDesc><div><p><s>and induces oxidative stress through a modulation of NOS activity.</s><s>Short-term exposure causes an increase, and long term exposure a decrease of NOS activity in human endothelial cells[52].</s><s>tiglylcarnitine (C5:1) and glutaconylcarnitine (C5:1-DC)[53, 54].</s><s>The C5:1 is listed within a panel of biomarkers patented for the diagnosis of kidney disease[55].</s><s>Branched chain amino acids (BCAA, leucine, isoleucine and valine) constitute 40% of all amino acids from daily nutrition intake[56].</s><s>Changes in BCAA concentrations are risk biomarkers of diabetes type patients with CKD showed a decrease in BCAA which might as well be caused by malnutrition[60].</s><s>Metabolic exchange of BCAA between different tissues was observed to modulate BCAA metabolism in CKD[61].</s><s>BCAA can enter energy generation in tricarboxylic acid cycle (TCA) through the action of branched-chain alpha-keto acid dehydrogenase complex[62].</s><s>Branched translation via elF4E[64].</s><s>eNOS was shown to support both mitochondrial biogenesis and metabolic activity[65].</s><s>The restoration effects seen in ET+/+eNOS-/-animals in our study interpretation of the processes is summarized in Fig.9and is based on published and our own records.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>Fig. 9 .</head><label>9</label><figDesc><div><p><s>Fig. 9. Hypothesis: ET-1 overexpression on top of eNOS knockout may cause functional recovery of mitochondria in ET+/+eNOS-/-crossbred mice.</s><s>ET-1 overexpression on top of eNOS knockout is associated xidative properties (normalization of monounsaturated fatty acids levels) possibly due to NF B, Nrf2, and enzymes are given in orange rounded rectangles.</s><s>Abbreviations: BCKDC -branched-chain alpha-keto acid dehydrogenase complex, PEMT -phosphatidyl ethanolamine methyltransferase, eNOS-endothelial nitric</s></p></div></figDesc><graphic coords="13,129.53,117.25,343.93,229.21" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="4,93.47,126.61,409.33,313.09" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>and mouse</s></p></div></figDesc><table><row><cell>Cellular Physiology Cellular Physiology and Biochemistry and Biochemistry</cell><cell>DOI: 10.1159/000438516 Published online: October 29, 2015</cell><cell>1477</cell></row><row><cell></cell><cell>Tsuprykov et al: ET+/+eNOS-/-Genotype is Renoprotective</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>CellPhysiol Biochem 2015;37:1474-1490</s></p></div></figDesc><table /><note><p><s>DOI: 10.1159/000438516 Published online: October 29, 2015</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Systolic Blood Pressure.</s><s>Systolic blood pressure in 3 and 9 months old mice, mm Hg.</s><s>Values are given as mean ± SEM.</s></p></div></figDesc><table /><note><p><s>* P P P &lt; 0.001 vs WT</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>mean ± SEM. * P P &lt; 0.001 vs eNOS-/-</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4 .</head><label>4</label><figDesc></figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© 2015 The Author(s). Published by S. Karger AG, Basel www.karger.com/cpb</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>This study was supported in part by a grant from the German Federal Ministry of Disclosure Statement</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<author>
			<persName><forename type="first">T</forename><surname>Quaschning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Koçak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-H</forename><surname>Neumayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Galle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
		<title level="m">Increase in nitric oxide bioavailability 3</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Endothelin antagonists for diabetic and non-diabetic chronic kidney disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Kohan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Pollock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main">Hocher: Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase</title>
		<author>
			<persName><forename type="first">C: Arginine ; Nat Clin Pract</forename><surname>Baylis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Theuring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Galle</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>arginine analogs and nitric oxide production in chronic kidney disease</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Endothelin-1 overexpression restores diastolic</title>
		<author>
			<persName><forename type="first">B</forename><surname>Albrecht-Küpper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Theuring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Stasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B ; T</forename><surname>Hocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Neumayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Schleuning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Theuring F: Endothelin-1 transgenic mice develop 1389</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mashimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Moskowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bevan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Fishman</surname></persName>
		</author>
		<title level="m">Hypertension in mice Stasch JP, Hocher B.: Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Mewes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Meitinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>De Angelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kronenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Soranzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Spector</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Adamski</surname></persName>
		</author>
		<imprint>
			<biblScope unit="page">141</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Erdmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Grundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hammond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>De Angelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kastenmüller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Köttgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kronenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Mangino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Illig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Spector</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Adamski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Soranzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gieger</surname></persName>
		</author>
		<imprint>
			<publisher>Human metabolic</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<author>
			<persName><forename type="first">O</forename><surname>Horakova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Medrikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Van Schothorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bunschoten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Flachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bardova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Janovska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Suhre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Adamski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Köttgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meisinger</surname></persName>
		</author>
		<title level="m">Metabolites associate with kidney function decline and 12</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">2669. and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of 232</title>
		<author>
			<persName><forename type="first">T</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Glushakova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Campbell-Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuzawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Atkinson</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
		<idno type="DOI">10.1159/000438516</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Physiol Biochem</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1474" to="1490" />
			<date type="published" when="2015-10-29">2015. October 29. 2015</date>
		</imprint>
	</monogr>
	<note>Published online</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
